Hematopoietic stem cell transplantation in Pakistan – country report by Adil, Salman Naseem et al.
eCommons@AKU
Department of Pathology and Laboratory Medicine Medical College, Pakistan
December 2017
Hematopoietic stem cell transplantation in Pakistan
– country report
Salman Naseem Adil
Aga Khan University, salman.adil@aku.edu
Natasha Ali
Aga Khan University, natasha.ali@aku.edu
Parvez Ahmed
Armed Forces Bone Marrow Transplant Centre
Tariq Mahmood Satti
Armed Forces Bone Marrow Transplant Centre
Qamar un Nisa Chaudhry
Armed Forces Bone Marrow Transplant Centre
See next page for additional authors
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_pathol_microbiol
Part of the Hematology Commons, Oncology Commons, and the Pathology Commons
Recommended Citation
Adil, S. N., Ali, N., Ahmed, P., Satti, T. M., Chaudhry, Q., Shamsi, T. S., Mahmood, S. K., Ansari, S., Rashid, K. (2017). Hematopoietic
stem cell transplantation in Pakistan – country report. Hematology/Oncology and Stem Cell Therapy, 10(4), 303-304.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/1163
Authors
Salman Naseem Adil, Natasha Ali, Parvez Ahmed, Tariq Mahmood Satti, Qamar un Nisa Chaudhry, Tahir
Sultan Shamsi, Syed Kamran Mahmood, Saqib Ansari, and Kamran Rashid
This report is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/1163
Hematopoietic stem cell transplantation in
Pakistan – country report
Parvez Ahmed a,*, Tahir Sultan Shamsi b, Salman Naseem Adil c,
Tariq Mahmood Satti a, Qamar un Nisa Chaudhry a, Syed Kamran Mahmood a,
Kamran Rashid d, Saqib Ansari b, Natasha Ali c, Tariq Ghafoor a
aArmed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan
bNational Institute of Blood Diseases, Karachi, Pakistan
cAga Khan University Hospital, Karachi, Pakistan
d Shifa International Hospital, Islamabad, Pakistan
Received 3 January 2017; accepted 9 May 2017
Available online 22 July 2017
Pakistan is 6th largest country with over 180 million pop-
ulation. Overall life expectancy has increased from an aver-
age of 45–66 in last 70 years [1]. Annual per capita health
expenditure is 39 $, which is comparatively lower than other
developing countries [2]. Consanguineous marriages have
affected a great number of population in terms of heredi-
tary disorders. Thalassemia, bone marrow failure syn-
dromes, immunodeficiency states and hemophilia are
common genetic disorders with high disease burden [3].
These diseases can be prevented otherwise by appropriate
genetic counseling. Inadequate social security system, lack
of awareness, inefficient prevention programs and defi-
ciency of advanced diagnostics facilities, worsen the situa-
tion. Mostly of the genetic disorders are incurable and
result in disability or death. With technological advance-
ment and research in field of hematopoietic stem cell trans-
plantation, it is emerging as possible cure of genetic
disabilities. Establishment of transfusion facility, platelet
separation and storage methods, developments in HLA typ-
ing and acquisition of knowledge in radiotherapy, laid the
foundation for stem cell research in Pakistan back in 1978.
Technology transfer started in 1992, when respective indi-
viduals were trained in various aspects of bone marrow
transplantation. Hematopoietic stem cell transplant (HSCT)
activity started in 1995 with auto HSCT transplant on a
patient with AML, but till 2004 only two transplant centers
were functional with less than 50 transplants per year [4].
Currently there are 8 stem cell transplant centers accred-
ited by national statutory body. In last 2 decades, 1851
HSCT have been carried out [5]. Most of the patients
(n = 1592) were of Allogenic (allo) HSCT and others were
auto HSCT (n = 259). Primary indications for allo HSCT were
beta thalassemia (n = 603), aplastic anemia (n = 540) and
acute leukemias (n = 169). The autologous transplants were
carried out mainly for lymphomas (n = 155), multiple mye-
loma (n = 67) and AML (n = 19). Peripheral blood stem cells
(PBSC) were used as source of stem cells in 903 cases, it
was used as source, followed by bone marrow in 671 cases.
While for 277 cases both the PBSC and marrow infusion were
used simultaneously. Still the number of patients are few
compared to the actual burden of diseases. For the year
2016, 9 persons per 10 million population underwent HSCT.
http://dx.doi.org/10.1016/j.hemonc.2017.05.026
1658-3876/ 2017 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
* Corresponding author.
E-mail address: parvez101@yahoo.com (P. Ahmed).
Hematol Oncol Stem Cell Ther (2017) 10, 303–304
Avai lab le a t www.sc ienced i rec t .com
ScienceDirect
journal homepage: www.elsev ier .com/ locate /hemonc
Downloaded for Anonymous User (n/a) at Aga Khan University from ClinicalKey.com by Elsevier on February 12, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
The field of HSCT has expanded globally with the advent of
cord blood stem cells storage and establishment of matched
unrelated donor (MUD) registries in many countries. Pak-
istan being a resource-constrained country lacks the infras-
tructure for MUD registry or cord blood banks. The
transplant activity is likely to increase due to recent devel-
opments in haplo identical HSCT. So far 35 haplo-identical
transplants have been carried out in the country with
encouraging results. With only a handful transplant centers;
the waiting list for these patients is ever growing. Moreover,
advanced health care facilities and diagnostics centers, are
confined to the three larger cities, and only a hand full of
population has access to that. Absence of registry for trans-
plant and bone marrow donors, unavailability of cord blood
banks, expensive chemotherapeutic agents and non-avail-
ability of monoclonal antibodies, remains obstacles in
development of this newly emerging field.
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